Sökning: onr:"swepub:oai:DiVA.org:liu-117376" >
Enhanced anti-tumor...
-
Campbell, DiahnnUniversity of Calif San Diego, CA 92093 USA
(författare)
Enhanced anti-tumor immune responses and delay of tumor development in human epidermal growth factor receptor 2 mice immunized with an immunostimulatory peptide in poly(D, L-lactic-co-glycolic) acid nanoparticles nanoparticles
- Artikel/kapitelEngelska2015
Förlag, utgivningsår, omfång ...
-
2015-03-31
-
BioMed Central,2015
-
electronicrdacarrier
Nummerbeteckningar
-
LIBRIS-ID:oai:DiVA.org:liu-117376
-
https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-117376URI
-
https://doi.org/10.1186/s13058-015-0552-9DOI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:art swepub-publicationtype
Anmärkningar
-
Funding Agencies|US Army Medical Research and Material Command from the National Institutes of Health/NCI [W81XWH-07-1-0412, 5U54CA119335]
-
Introduction Cancer vaccines have the potential to induce curative anti-tumor immune responses and better adjuvants may improve vaccine efficacy. We have previously shown that Hp91, a peptide derived from the B box domain in high-mobility group box protein 1 (HMGB1), acts as potent immune adjuvant. Method In this study, Hp91 was tested as part of a therapeutic vaccine against human epidermal growth factor receptor 2 (HER2) positive breast cancer. Results Free peptide did not significantly augment immune responses but, when delivered in poly(D, L-lactic-co-glycolic) acid nanoparticles (PLGA-NPs), robust activation of dendritic cells (DCs) and increased activation of HER2 specific T cells was observed in vitro. Vaccination of HER2NEU transgenic mice, a mouse breast cancer model that closely mimics the immune modulation and tolerance in some breast cancer patients, with Hp91 loaded PLGA-NPs enhanced the activation of HER2 specific cytotoxic T lymphocyte (CTL) responses, delayed tumor development, and prolonged survival. Conclusion Taken together these findings demonstrate that the delivery of the immunostimulatory peptide Hp91 inside PLGA-NPs enhances the potency of the peptide and efficacy of a breast cancer vaccine.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Saenz, RebeccaUniversity of Calif San Diego, CA 92093 USA
(författare)
-
Bharati, Ila S.University of Calif San Diego, CA 92093 USA
(författare)
-
Seible, DanielUniversity of Calif San Diego, CA 92093 USA
(författare)
-
Zhang, LiangfangUniversity of Calif San Diego, CA 92093 USA
(författare)
-
Esener, SadikUniversity of Calif San Diego, CA 92093 USA
(författare)
-
Messmer, BradleyUniversity of Calif San Diego, CA 92093 USA
(författare)
-
Larsson, MarieLinköpings universitet,Avdelningen för mikrobiologi och molekylär medicin,Hälsouniversitetet(Swepub:liu)marla67
(författare)
-
Messmer, DavorkaUniversity of Calif San Diego, CA 92093 USA
(författare)
-
University of Calif San Diego, CA 92093 USAAvdelningen för mikrobiologi och molekylär medicin
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:Breast Cancer Research: BioMed Central17:481465-54111465-542X
Internetlänk
Hitta via bibliotek
Till lärosätets databas